Vaccines are critical to disease prevention and infection control ... types of challenges by researching self-amplifying RNA (saRNA) and novel antigen-design technologies. saRNA is a novel vaccine ...

Harnessing the targeted gene manipulation in cells enabled by ChaESAR, Chimeron is developing a compelling portfolio of innovative saRNA-based vaccines and therapeutics for infectious diseases ...

UK biotech MiNA Therapeutics has signed up another big pharma partner for its small activating RNA (saRNA) platform ... neurodegenerative diseases and pain. It's also pledging milestones of ...

The initiative will focus on self-amplifying RNA (saRNA)-based vaccines for both human and animal health, employing a One Health approach to bolster defences against zoonotic diseases. The ...